Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants
Clinical trial NCT06648031 · COMPLETED
Trial details
- NCT number
- NCT06648031
- Sponsor
- Lexaria Bioscience Corp.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-04
- Primary completion
- 2025-07-31
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.